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ABSTRACT Candida albicans is an opportunistic fungal pathogen responsible for
superﬁcial and life-threatening infections in humans. During mucosal infection, C. al-
bicans undergoes a morphological transition from yeast to invasive ﬁlamentous hy-
phae that secrete candidalysin, a 31-amino-acid peptide toxin required for virulence.
Candidalysin damages epithelial cell plasma membranes and stimulates the activat-
ing protein 1 (AP-1) transcription factor c-Fos (via p38–mitogen-activated protein ki-
nase [MAPK]), and the MAPK phosphatase MKP1 (via extracellular signal-regulated ki-
nases 1 and 2 [ERK1/2]–MAPK), which trigger and regulate proinﬂammatory cytokine
responses, respectively. The candidalysin toxin resides as a discrete cryptic sequence
within a larger 271-amino-acid parental preproprotein, Ece1p. Here, we demonstrate
that kexin-like proteinases, but not secreted aspartyl proteinases, initiate a two-step
posttranslational processing of Ece1p to produce candidalysin. Kex2p-mediated pro-
teolysis of Ece1p after Arg61 and Arg93, but not after other processing sites within
Ece1p, is required to generate immature candidalysin from Ece1p, followed by
Kex1p-mediated removal of a carboxyl arginine residue to generate mature candida-
lysin. C. albicans strains harboring mutations of Arg61 and/or Arg93 did not secrete
candidalysin, were unable to induce epithelial damage and inﬂammatory responses
in vitro, and showed attenuated virulence in vivo in a murine model of oropharyn-
geal candidiasis. These observations identify enzymatic processing of C. albicans
Ece1p by kexin-like proteinases as crucial steps required for candidalysin production
and fungal pathogenicity.
IMPORTANCE Candida albicans is an opportunistic fungal pathogen that causes
mucosal infection in millions of individuals worldwide. Successful infection requires
the secretion of candidalysin, the ﬁrst cytolytic peptide toxin identiﬁed in any hu-
man fungal pathogen. Candidalysin is derived from its parent protein Ece1p. Here,
we identify two key amino acids within Ece1p vital for processing and production of
candidalysin. Mutations of these residues render C. albicans incapable of causing epi-
thelial damage and markedly reduce mucosal infection in vivo. Importantly, candida-
lysin production requires two individual enzymatic events. The ﬁrst involves process-
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ing of Ece1p by Kex2p, yielding immature candidalysin, which is then further
processed by Kex1p to produce the mature toxin. These observations identify impor-
tant steps for C. albicans pathogenicity at mucosal surfaces.
KEYWORDS Candida albicans, candidalysin, fungal infection, kexin, mucosal
immunity
Fungal infections are a major cause of morbidity and mortality in the globalpopulation with species of Candida, Cryptococcus, Pneumocystis, and Aspergillus
contributing to an estimated 2 million life-threatening infections reported each year (1).
Candida albicans causes both superﬁcial infections at mucosal surfaces (e.g., thrush),
which affect millions of people worldwide, and life-threatening bloodstream infections
in susceptible individuals (1, 2). C. albicans pathogenicity is dependent upon multiple
virulence factors, but the yeast-to-hypha morphological transition is recognized as
being the most important for mucosal infections. C. albicans hypha formation is
essential for epithelial damage and immune activation, and it was recently discovered
that both processes are driven by the secretion of candidalysin from hyphae (3).
Candidalysin is an amphipathic 31-amino-acid (aa) cytolytic peptide toxin that is vitally
important for C. albicans mucosal infection and functions by destabilizing the integrity
of plasma membranes and activating epithelial immunity via the activating protein 1
(AP-1) transcription factor c-Fos (via the p38–mitogen-activated protein kinase [MAPK]
pathway), and the MAPK phosphatase MKP1 (via the extracellular signal-regulated
kinase 1 and 2 [ERK1/2]–MAPK pathway) (3, 4).
Candidalysin is derived from a larger parental preproprotein (Ece1p) encoded by the
C. albicans ECE1 gene. The Ece1p preproprotein is thought to be processed in the
endoplasmic reticulum (ER) and the Golgi complex and consists of 271 aa including a
signal peptide for secretion (recognized by the signal peptidase) (5) and seven dibasic
lysine-arginine (KR) motifs (see Fig. S1A in the supplemental material) that are recog-
nized by the Golgi complex-associated endoproteinase Kex2p in vitro (6, 7). C. albicans
Kex2p is a member of a family of eukaryotic proprotein protease enzymes that includes
proprotein convertase 1 (PC1), PC2, and furin, which possess catalytic domains homol-
ogous to the degradative serine proteases of the subtilisin family (8). These subtilisin/
kexin-like proteases have major physiological roles and are associated with various
pathologies, including Alzheimer’s disease and tumorigenesis, and controlling infection
in humans (9). Notably, the subtilisin/kexin-like proteases have been implicated in the
activation of various bacterial toxins, including diphtheria toxin, Pseudomonas aerugi-
nosa exotoxin A, botulinum neurotoxin, and pore-forming toxins such as aerolysin,
which are produced as inactive, unprocessed forms that are activated by proteolytic
processing (10). Therefore, we hypothesized that the processing of Ece1p by Kex2p to
generate candidalysin may be required for C. albicans pathogenicity.
Although recombinant Ece1p is a substrate of Kex2p-mediated proteolysis in vitro
(6), it is not clear which KR motifs are important for targeted proteolysis of Ece1p,
whether sequential Kex2p processing from the N or C terminus of Ece1p is required to
release candidalysin, or whether Kex2p processing of Ece1p is critical for in vivo
infections. To investigate the fundamental importance of Ece1p processing by Kex2p in
C. albicans pathogenicity, it is not possible to use a C. albicans kex2Δ/Δ mutant as this
mutant is unable to form hyphae and has severely attenuated ﬁtness (11). We previ-
ously showed that a kex2Δ/Δ mutant is unable to damage and activate epithelial cells
(3), but this cannot be attributed to defective Ece1p processing alone. To circumvent
these problems, we used site-directed mutagenesis to mutate each of the Kex2p
recognition sequences in Ece1p from lysine-arginine (KR) to lysine-alanine (KA), indi-
vidually and in combination. Mutation of arginine to alanine replaces the charged polar
side chain (Arg) with a smaller nonpolar side chain (Ala) and has been shown to reduce
the efﬁciency of site-speciﬁc kexin-mediated proteolysis (12).
Using this approach, we demonstrate that Kex2p processing of Ece1p at Arg61 and
Arg93 is vital for the generation of candidalysin, the induction of epithelial damage and
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immunity, and C. albicans pathogenicity. Furthermore, we show that sequential Kex2p
processing from the N or C terminus of Ece1p is not required to release candidalysin.
We also conﬁrm that a second proteolytic processing event required for the production
of mature candidalysin is dependent upon Kex1p, a carboxypeptidase that, like Kex2p,
is associated with the Golgi complex in yeast (13). Collectively, these studies demon-
strate that Arg61 and Arg93 of C. albicans Ece1p are indispensable residues required for
a sequential, two-step processing event involving targeted proteolysis of Ece1p and
candidalysin maturation and that this processing is required for C. albicans pathoge-
nicity and immune activation.
RESULTS
Construction and characterization of alanine substitution mutants in C. albi-
cans Ece1p. To investigate the importance of the Kex2p recognition motifs within
C. albicans Ece1p and their role in Ece1p processing, site-directed mutagenesis was
used to mutate the arginine residue in each KR motif to an alanine (KA). The identity
of each mutation was conﬁrmed by DNA sequencing. The mutagenized constructs were
introduced into a C. albicans ece1Δ/Δ null mutant (3) as the sole source of ECE1 to
create a panel of alanine substitution mutants (see Fig. S2 in the supplemental material)
that allowed the importance of each KR site in Ece1p to be interrogated individually
and in combination.
All mutants were viable and displayed no difference in growth rate in yeast
extract-peptone-dextrose (YPD) liquid culture at 30°C. All mutants ﬁlamented normally
under hypha-inducing conditions (RPMI 1640, 37°C, 3 h), and no signiﬁcant differences
in hyphal length were observed between the mutants and parental controls (Fig. S3A).
The ECE1 gene is strongly expressed during hyphal growth (3, 14). To conﬁrm that
expression of ECE1 was not affected by the introduction of the alanine substitutions, we
quantiﬁed the ability of each mutant to express ECE1 under hypha-inducing conditions.
No differences in ECE1 expression were observed between any of the alanine substi-
tution mutants or control strains (Fig. S3B).
Ece1p Arg61 and Arg93 are essential for C. albicans-mediated epithelial dam-
age and activation in vitro. To determine whether processing of Ece1p by Kex2p is
required for candidalysin-mediated damage to epithelial cells, we infected TR146 oral
epithelial cells with the panel of alanine substitution mutants (Fig. S2) and quantiﬁed
lactate dehydrogenase (LDH) activity in the culture supernatant as a marker of host
cellular damage. Infection of epithelial cells with the isogenic wild-type strain
(BWP17CIp30, here referred to as “WT”) or the ece1Δ/ΔECE1 parental control strain
resulted in signiﬁcant cellular damage compared to the vehicle (negative) control.
Similarly, mutants expressing R31A, R126A, R160A, R194A, and R228A substitutions in
Ece1p also caused signiﬁcant damage. However, mutants expressing an alanine sub-
stitution at position 61 or 93 in Ece1p, and thus predicted to be unable to release
candidalysin, were unable to damage epithelial cells (Fig. 1A). Strains expressing Ece1p
containing both mutations (R61A  R93A) or all KR sites mutated to KA (ALL KA) were
also unable to cause damage.
Candidalysin activates c-Fos and MKP1 signaling in epithelial cells, resulting in
proinﬂammatory responses (3, 4, 15). To assess the role of Ece1p processing in signal
pathway activation, epithelial cells were infected with the panel of Ece1p alanine
substitution mutants in vitro, and c-Fos production/MKP1 phosphorylation was as-
sessed by Western blotting. The c-Fos/p-MKP1 response was induced strongly by the
WT, by the ece1Δ/ΔECE1 parental control, and by strains expressing mutations that do
not affect the release of candidalysin from Ece1p (R31A, R126A, R160A, R194A, and
R228A). In contrast, epithelial cells infected with vehicle (negative control) or with R61A,
R93A, R61A R93A, or ALL KA mutant strains did not induce c-Fos production or MKP1
phosphorylation (Fig. 1B), and the lack of c-Fos activity was conﬁrmed using a c-Fos
DNA binding assay (Fig. 1C).
Candidalysin induces the secretion of several cytokines, including interleukin-1
(IL-1), IL-1, IL-6, granulocyte colony-stimulating factor (G-CSF) and granulocyte-
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FIG 1 Alanine substitutions at positions 61 and 93 of Ece1p render C. albicans incapable of damaging
or activating TR146 oral epithelial cells in vitro. (A) Epithelial cell damage induced by C. albicans Ece1p
alanine substitution mutants. Epithelial cells were exposed to Ece1p alanine substitution mutants for
24 h, and levels of cell damage were assessed by LDH assay. Statistics are applied relative to the
ece1Δ/ΔECE1 parental control (n  5 biological repeats). (B) Western blot analysis of epithelial cells
infected with C. albicans alanine substitution mutants. Epithelial cell lysates (20 g total protein) were
probed with anti-c-Fos and anti-p-MKP1 antibodies. One representative blot presented (from n  3
biological repeats). (C) Analysis of c-Fos DNA binding activity from epithelial cells infected with C. albicans
alanine substitution mutants. Statistics are applied relative to the vehicle control (n  3 biological
repeats). (D to H) Quantiﬁcation of cytokines (IL-1, IL-1, IL-6, G-CSF, and GM-CSF) secreted from
epithelial cells in response to alanine substitution mutants of C. albicans Ece1p. Statistics are applied
relative to ece1Δ/ΔECE1 parental control (n  3 biological repeats). (A and C to H) Data are presented
as fold change relative to vehicle control (dashed line)  standard deviation (SD). Statistical signiﬁcance
was calculated using one-way ANOVA with a post hoc Dunnett comparison test. ****, P 0.0001; ***, P
0.001; **, P  0.01; *, P  0.05.
Richardson et al. ®
January/February 2018 Volume 9 Issue 1 e02178-17 mbio.asm.org 4
 
m
bio.asm
.org
 o
n
 January 26, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
macrophage colony-stimulating factor (GM-CSF) (3). Therefore, we quantiﬁed the se-
cretion of these cytokines following infection with the panel of alanine substitution
mutants (Fig. 1D to H). Epithelial cells responded to the WT, ece1Δ/ΔECE1 parental
control, and mutant strains that do not affect the release of candidalysin (R31A, R126A,
R160A, R194A, and R228A), by secreting signiﬁcant levels of IL-1, IL-1, IL-6, G-CSF,
and GM-CSF. In contrast, epithelial cytokine secretion was abolished in response to
infection with the mutant strains predicted to affect the release of candidalysin (R61A,
R93A, R61A  R93A, and ALL KA). Taken together, these data indicate that Arg61 and
Arg93 within C. albicans Ece1p are essential for the release of candidalysin and the
induction of epithelial damage and immune activation in vitro.
R61A and R93A mutations in C. albicans Ece1p result in attenuated secretion of
candidalysin. To conﬁrm whether mutation of Kex2p recognition sites within Ece1p
impaired candidalysin secretion, hyphal growth was induced in mutant and control
strains, and hypha-secreted peptides were analyzed by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). The number of peptide spectrum matches (PSMs)
corresponding to candidalysin was determined (Table 1; amino acid sequences of
detected peptides and nomenclature conventions are presented in Table S1 in the
supplemental material).
The C. albicans reference strain SC5314 (16) and the isogenic WT strain
BWP17CIp30 secreted candidalysin in the absence of epithelial cells under hypha-
inducing conditions, and BWP17CIp30 secreted candidalysin when cultured in the
presence of epithelial cells for 3 h and 18 h. No candidalysin PSMs were detected from
an ece1Δ/Δ null mutant or a mutant lacking the candidalysin-encoding region of ECE1
(ece1Δ/ΔECE1Δ184–279). Substantial candidalysin PSMs were obtained from the ece1Δ/
ΔECE1 parental control, and candidalysin was the most abundant peptide detected in
the strains harboring alanine substitutions that did not ﬂank candidalysin (R31A, R126A,
R194A, and R228A; the exception was the R160A strain, where candidalysin was the
second most abundant peptide). In contrast, secretion of candidalysin from strains that
harbored alanine substitutions which ﬂanked candidalysin (R61A, R93A, R61A  R93A,
and ALL KA) was absent or severely attenuated (Table 1). These data demonstrate that
Kex2p recognition of arginine residues at positions 61 and 93 within Ece1p is required
for efﬁcient release of candidalysin.
LC-MS/MS analysis of peptides secreted from R61A and R93A mutants demonstrated
that while candidalysin (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK) displayed minimal PSM
values relative to total PSMs (Table 1), larger “fusion” peptides containing the mutated
Kex2p recognition site (KA) were detected in the exhausted culture medium (Data
Set S1), suggesting that Kex2p was unable to process Ece1p at these mutated locations.
Fusion peptides were secreted from all alanine substitution mutants except the R126A
and R228A mutants. Collectively, these data indicate that the KR motifs of Ece1p are
required for enzymatic processing of the full-length protein into peptide fragments and
that Arg61 and Arg93 are critical for the secretion of candidalysin.
C. albicans Kex1p is required for candidalysin maturation, epithelial damage,
and immune activation. The candidalysin toxin was initially predicted to terminate in
a dibasic lysine-arginine (KR) motif based upon Kex2p substrate speciﬁcity, and a
peptide corresponding to this sequence (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR) was
capable of damaging epithelial cells and activating the c-Fos/MKP1 signaling circuits in
vitro (3). However, subsequent analysis of the hypha-secreted peptides revealed that
secreted candidalysin lacks the C-terminal arginine residue (3). This observation implied
the potential involvement of a carboxypeptidase enzyme and a second processing step.
In addition to the Kex2p endoproteinase, the carboxypeptidase Kex1p is also located in
the Golgi complex of yeast (13), and an ortholog of Kex1p exists in C. albicans. Given
these observations, Kex1p was therefore a compelling candidate for the removal of the
C-terminal arginine residue and production of mature candidalysin and was conﬁrmed
to do so in a previous study (3).
Further analysis of the hypha-secreted peptides of a kex1Δ/Δ null mutant (Table 1)
revealed an approximately 7-fold reduction in candidalysin PSM values relative to total
Candidalysin Maturation from C. albicans Ece1p ®
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PSM values compared with a kex1Δ/ΔKEX1 reintegrant control (3.2% versus 23.5%,
respectively). Importantly, analysis of WT and the kex1Δ/ΔKEX1 strain revealed that
mature candidalysin (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK) was the predominant pep-
tide secreted from both strains. However, upon disruption of the KEX1 gene (kex1Δ/Δ),
immature candidalysin (SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR) was the dominant pep-
tide produced (Table S2). Collectively, these data conﬁrm that C. albicans Kex1p
carboxypeptidase activity is required for the production of mature candidalysin.
To determine whether C. albicans Kex1p activity was required for cellular damage,
signal pathway activation, and the induction of proinﬂammatory cytokines, we infected
TR146 epithelial monolayers with a kex1Δ/Δ null mutant. In contrast to the WT and
TABLE 1 LC-MS/MS analysis of Ece1p secreted peptidese
Strain namea
Conditions and
replicateb
Total no.
of PSMsc
No. of PSMs for
candidalysinc
Most abundant sequenced
(no. of PSMs)
SC5314 (1) 815 197 P7N_DT-19 (268)
(2) 416 189 Candidalysin
BWP17CIp30 (1) 2,011 715 Candidalysin
(2) 1,576 730 Candidalysin
(3) 112 79 Candidalysin
3 h culture 595 422 Candidalysin
TR146 epithelial cell infection, 3 h (1) 154 128 Candidalysin
TR146 epithelial cell infection, 3 h (2) 81 79 Candidalysin
TR146 epithelial cell infection, 18 h 209 97 Candidalysin
Pepstatin A 794 335 Candidalysin
Pepstatin A vehicle control 1,661 966 Candidalysin
ece1Δ/Δ (1) 0 0 NA
(2) 0 0 NA
ece1/ECE1 1,090 510 Candidalysin
ece1/ECE1Δ184279 188 0 P7C_SV-12 (46)
kex1Δ/Δ (1) 2,681 80 P8N_DK-13 (604)
(2) 1,369 49 P8N_DK-13 (338)
(3) 559 19 P7N_DR-20 (140)
kex1/KEX1 468 110 P7N_DT-19 (228)
R31A (1) 489 154 Candidalysin
(2) 483 273 Candidalysin
R61A (1) 1,441 92 P2-P3K_DK-61 (370)
(2) 179 3 P2-P3K_DK-61 (78)
R93A (1) 338 15 P7C_SV-12 (108)
(2) 90 0 P7N_DT-19 (26)
R126A (1) 371 133 Candidalysin
(2) 323 213 Candidalysin
R160A 443 146 P7N_DT-19 (189)
R194A 1,169 752 Candidalysin
R228A 418 276 Candidalysin
R61A  R93A (1) 464 0 P7N_DT-19 (200)
(2) 127 4 P7N_SV-12 (35)
ALL KA 186 0 P5N_DA-19 and
P8C_DA-13 (20)
aGenotype details are presented in Table S3.
bNumbers in parentheses indicate independent experimental replicates.
cPSM values are semiquantitative.
dAmino acid sequences of detected peptides and nomenclature conventions are presented in Table S1. PSM, peptide spectrum match; NA, not applicable. Full details
of LC-MS/MS data sets and sequence alignments are provided in Data Set S1.
eSamples were prepared as previously described (3) unless otherwise speciﬁed.
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kex1Δ/ΔKEX1 reintegrant control strains, the kex1Δ/Δ null mutant was unable to cause
damage or induce c-Fos production/DNA binding, MKP1 phosphorylation, or cytokine
secretion from epithelial cells (Fig. S4). These data demonstrate that Kex1p processing
is also required for epithelial damage and host recognition of candidalysin.
Saps are not required for Ece1p processing or candidalysin production. Like
Kex2p, Kex1p is likely to have multiple targets, including other proteases. The obser-
vations made with the kex1Δ/Δ null mutant could therefore be an indirect effect of the
absence of Kex1p, which could be required for full activity of other proteases possibly
involved in the maturation of candidalysin. The secreted aspartyl proteinases (Saps) are
a family of enzymes that exhibit broad substrate speciﬁcity (17). Pepstatin A is a potent
inhibitor of most Sap activity (although Sap7p is not inhibited by pepstatin A, and
Sap9p and Sap10p exhibit reduced sensitivity to such inhibition under certain physi-
ological conditions [18, 19]), and epithelial cells treated with pepstatin A are partially
protected from fungal damage in vitro (20). In light of these observations, we investi-
gated whether Saps may play a role in Ece1p processing and candidalysin production.
Therefore, we cultured WT C. albicans under hypha-inducing conditions in the presence
of pepstatin A and analyzed the secreted peptides using LC-MS/MS (Table 1). Candida-
lysin was secreted from WT hyphae in the presence of pepstatin A, and no reduction
in candidalysin PSMs was observed following Sap inhibition. These observations sug-
gest that Saps and/or other extracellular aspartyl proteinases (e.g., Bar1p [21]) targeted
by pepstatin A are not required for Ece1p processing or candidalysin production, at
least when inhibited extracellularly.
Arg93 is required for efﬁcient processing of C. albicans Ece1p. Candidalysin
possesses a hydrophobic N-terminal region (Ece1p62–85; SIIGIIMGILGNIPQVIQIIMSIV)
and a hydrophilic C terminus (Ece1p8692; KAFKGNK) (Fig. S1B). A previous in vitro
analysis of mutated candidalysin peptides indicated that the positively charged C
terminus of candidalysin is required for epithelial damage (3). Having demonstrated
that Arg61 and Arg93 are required for efﬁcient enzymatic processing of Ece1p, we
questioned whether replacement of arginine with alanine at position 93 could never-
theless result in successful (albeit inefﬁcient) proteolytic cleavage of mutated Ece1p,
generating a secreted candidalysin toxin with a modiﬁed C terminus (amino acid
sequence SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKA; Ece1p62–93KA). LC-MS/MS analysis of
hypha-secreted peptides from the R93A mutant revealed the presence of this modiﬁed
candidalysin toxin terminating in lysine-alanine (Data Set S1). However, the PSM value
for this modiﬁed toxin was very low (PSM  14; complete LC-MS/MS data set is
provided in Data Set S1), and infection of epithelial cells with the R93A mutant did not
induce cellular damage, MKP1 phosphorylation, c-Fos DNA binding, or cytokine secre-
tion (Fig. 1).
To determine whether direct application of Ece1p62–93KA was capable of causing
epithelial damage and immune activation, we treated TR146 cells with different con-
centrations (70, 15, and 1.5 M; ranging from lytic to sublytic concentrations of mature
candidalysin [3]) of Ece1p62–93KA peptide and quantiﬁed LDH activity, c-Fos/p-MKP1
responses, and cytokine secretion (Fig. 2). At lytic concentrations, Ece1p62–93KA pep-
tide caused dose-dependent epithelial damage (Fig. 2A) and induced c-Fos and p-MKP1
responses (Fig. 2B) and secretion of cytokines (Fig. 2C to G). These data afﬁrm the ability
of Ece1p62–93KA to cause epithelial damage and immune activation in vitro and
suggest that the lack of epithelial damage and signaling observed in response to the
R93A mutant arose from inefﬁcient processing of Ece1p resulting in a severe reduction
in Ece1p62–93KA secretion.
Ece1p processing is required for the induction of mucosal immune responses
in vivo. Mucosal responses to inﬁltrating pathogenic C. albicans hyphae culminate in
the secretion of immunomodulatory cytokines and chemokines that collectively drive
innate immune responses leading to fungal clearance (reviewed in reference 22). To
determine whether enzymatic processing of C. albicans Ece1p is a driver of early-phase
host immune responses in vivo, we used a nonimmunosuppressed murine model of
Candidalysin Maturation from C. albicans Ece1p ®
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oropharyngeal candidiasis (OPC). WT mice were infected with positive-control strains
(WT and ece1Δ/ΔECE1), negative-control strains (ece1Δ/Δ and ece1Δ/ΔECE1Δ184–279),
a candidalysin-secreting alanine substitution mutant (R31A), and alanine substitution
mutants that showed a marked reduction in candidalysin secretion (R61A, R93A,
R61A  R93A, and ALL KA) for 24 h. Gene expression of Ccl20, Il1b, Il6, and Csf3 from
infected tongue tissue was assessed by quantitative PCR (qPCR) (Fig. 3).
Mice infected with the WT or ece1Δ/ΔECE1 strain or a candidalysin-secreting
alanine substitution mutant (R31A) responded by expressing increased levels of Ccl20,
Il1b, Il6, and Csf3 compared to the vehicle (negative) control (Fig. 3A to D). In contrast,
mice infected with the R61A, R93A, R61A  R93A, and ALL KA mutants were signiﬁ-
cantly attenuated in their ability to induce the expression of at least one proinﬂam-
matory gene compared with the ece1Δ/ΔECE1 parental control. Indeed, the impaired
response was similar to that of negative-control strains that did not express ECE1
(ece1Δ/Δ) or that lacked the candidalysin-encoding region of the ECE1 gene (ece1Δ/
ΔECE1Δ184–279). These data conﬁrm the importance of Ece1p processing and the
secretion of candidalysin for the early-phase activation of mucosal immune responses
to C. albicans hyphae in vivo.
Arg61 and Arg93 of C. albicans Ece1p are required for mucosal infection in
vivo. A C. albicans ece1Δ/Δ mutant and a mutant lacking the candidalysin-encoding
region of ECE1 (ece1Δ/ΔECE1Δ184–279) are severely diminished in their ability to cause
murine OPC and disease in a zebraﬁsh swim bladder model of mucosal infection (3). To
determine whether processing of Ece1p at Arg61 and Arg93 was required for successful
FIG 2 Ece1p62–93KA damages epithelial cells and activates c-Fos/p-MKP1 signaling and cytokine
secretion in vitro. (A) Epithelial cell damage induced by Ece1p62–93KA. Epithelial cells were exposed to
Ece1p62–93KA peptide (70, 15, and 1.5 M) for 24 h, and levels of cell damage were assessed by LDH
assay. (B) Western blot analysis of epithelial cells treated with Ece1p62–93KA peptide (15 M) for 2 h.
Epithelial cell lysates (20 g total protein) were probed with anti-c-Fos and anti-p-MKP1 antibodies. One
representative blot is presented (from n  3 biological repeats). (C to G) Quantiﬁcation of cytokines
(IL-1, IL-1, IL-6, G-CSF, and GM-CSF) secreted from epithelial cells in response to Ece1p62–93KA peptide
at 70, 15, and 1.5 M. (A and C to G) Data and statistical analysis are presented relative to vehicle control
(dashed line; n  3 biological repeats)  standard deviation (SD). Statistical signiﬁcance was calculated
using one-way ANOVA with a post hoc Dunnett comparison test. ****, P  0.0001; ***, P  0.001; **, P 
0.01; *, P  0.05.
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fungal infection in vivo, we challenged immunosuppressed WT mice with positive-
control strains (WT and ece1Δ/ΔECE1), negative-control strains (ece1Δ/Δ), and selected
alanine substitution mutants (R61A R93A and ALL KA) and quantiﬁed fungal burdens
in tongue tissue after 24 or 48 h. Mice infected with the WT or ece1Δ/ΔECE1 parental
control strain exhibited high levels of fungal burdens compared to sham-infected
(negative) controls after 24 h (Fig. 4A). Mice infected with the ALL KA mutant produced
a statistically signiﬁcant reduction in fungal burdens consistent with the ece1Δ/Δ
mutant. The R61A  R93A mutant also exhibited a (nonsigniﬁcant) reduction in fungal
burdens compared to the ece1Δ/ΔECE1 parental control. Repeat experiments at 48 h
showed that the ALL KA mutant (the R61A  R93A mutant was not tested) maintained
a signiﬁcant reduction in fungal burdens compared with the ece1Δ/ΔECE1 strain
(Fig. 4B). Taken together, these data demonstrate the importance of Ece1p processing
in C. albicans pathogenicity in oral infections.
DISCUSSION
Subtilisin/kexin-like proteases have fundamental physiological roles in nature and
have been associated with various pathologies, including Alzheimer’s disease, tumor-
igenesis, and the activation of multiple bacterial toxins (9, 10). The human fungal
pathogen C. albicans also possesses a Kex2p-like endoproteinase, and given that Ece1p
(the preproprotein harboring the peptide toxin candidalysin) is a known substrate for
FIG 3 Enzymatic processing of C. albicans Ece1p is required for efﬁcient host recognition of infecting
fungus in vivo. Nonimmunosuppressed mice were infected sublingually with selected C. albicans Ece1p
alanine substitution mutants and control strains for 24 h, and reverse transcriptase qPCR was performed
on tongue tissue RNA to quantify expression of Ccl20 (A), Il1b (B), Il6 (C), and Csf3 transcripts (D). Data are
presented as the mean of two biological repeats  standard deviation (SD). Statistical analysis is
presented relative to the ece1Δ/ΔECE1 parental control (total numbers of animals: sham, n  4; wild
type, n  4; ece1Δ/ΔECE1 strain, n  6; R31A, n  6; R61A, n  5; R93A, n  3; R61A  R93A, n  7;
ALL KA, n  7; ece1Δ/Δ strain, n  5; ece1Δ/ΔECE1Δ184–279 strain, n  5). Statistical signiﬁcance was
calculated using one-way ANOVA with a post hoc Dunnett comparison test. ****, P  0.0001; ***, P 
0.001; **, P  0.01; *, P  0.05.
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Kex2p in vitro (6), this study investigated the importance of Ece1p processing for the
production of candidalysin and C. albicans pathogenicity.
The endoproteinase Kex2p cleaves protein substrates and model peptides after
dibasic arginine-arginine (RR) and lysine-arginine (KR) motifs (8). Analysis of the C. al-
bicans genome has identiﬁed 147 potential Kex2p substrates, including Saps, the
hypha-wall protein Hwp1p (7), and Ece1p (6). However, a kex2Δ/Δ null mutant has
severely attenuated ﬁtness (11) and is unable to damage and activate epithelial cells
due to its inability to form hyphae (3). Since hypha formation is strongly associated with
ECE1 gene expression (3, 14), the lack of epithelial cell activation by the kex2Δ/Δ null
mutant cannot be attributed to defective Ece1p processing alone. Therefore, to address
the importance of Kex2p for Ece1p processing, we created a panel of alanine substi-
tution mutants in Ece1p in which each Kex2p recognition site (KR) was mutated,
individually or in combination. With this approach, we were able to circumvent any
off-target effects imposed by KEX2 disruption and address three outstanding questions
regarding Ece1p processing and candidalysin production: (i) which KR motifs are
important for candidalysin production and maturation, (ii) whether sequential Kex2p
processing from the N or C terminus of Ece1p is required for candidalysin release, and
(iii) whether Ece1p processing by Kex2p is critical for C. albicans pathogenicity and
mucosal infection.
C. albicansmutants (R61A, R93A, R61A R93A, and ALL KA) harboring replacements
of Arg61 and Arg93 with alanine within Ece1p, which directly ﬂank candidalysin (see
Fig. S2 in the supplemental material), were unable to induce epithelial damage, c-Fos
production, DNA binding, MKP1 phosphorylation, and cytokine secretion in vitro
(Fig. 1), which are key readouts of candidalysin activity (3). The same inability to induce
these phenotypes was also observed in C. albicans mutants lacking the ECE1 gene
(ece1Δ/Δ) (Fig. 1) or the candidalysin-encoding region of ECE1 (ece1Δ/ΔECE1Δ184–279)
(3). Notably, mutation of arginine residues that did not directly ﬂank candidalysin
(R31A, R126A, R160A, R194A, and R228A) failed to abrogate these responses. LC-MS/MS
analysis of hypha-secreted peptides revealed that mutations at Arg61 and Arg93
markedly reduced candidalysin secretion, whereas mutations at all other arginine
residues did not prevent secretion (Table 1). These data demonstrate that only the Arg
residues that directly ﬂank the candidalysin region (Arg61 and Arg93) are required for
the release of candidalysin from Ece1p and that these processing events are essential
for the ability of C. albicans hyphae to cause epithelial damage and immune activation.
Importantly, the data also demonstrate that sequential Kex2p processing from the N or
FIG 4 Enzymatic processing of C. albicans Ece1p is required for fungal pathogenesis in vivo. An
immunosuppressed murine model of oropharyngeal candidiasis (OPC) was infected with selected
C. albicans Ece1p alanine substitution mutants and control strains, and the number of CFU per gram of
tissue was enumerated after 24 h (A) and 48 h (B). Data represent two biological repeats. Total numbers
of animals in panel A: sham, n  4; wild type, n  12; ece1Δ/Δ strain, n  12; ece1Δ/ΔECE1 strain, n 
16; R61A R93A, n 21; ALL KA, n 11. Total numbers of animals in panel B: wild type, n 11; ece1Δ/Δ
strain, n  12; ece1Δ/ΔECE1 strain, n  11; ALL KA, n  12. Statistical analysis is presented relative to
the ece1Δ/ΔECE1 parental control. Statistical signiﬁcance was calculated using one-way ANOVA with a
post hoc Dunnett comparison test. Geometric mean is indicated. ****, P  0.0001; ***, P  0.001; *, P 
0.05.
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C terminus of Ece1p is not required for the release of candidalysin from the Ece1p
preproprotein.
Analysis of hypha-secreted peptides demonstrated that, in all cases, mutants with an
altered KA motif still secreted the modiﬁed fusion peptide into the extracellular milieu
(Table 1), strongly suggesting that secretion pathways are intact in all of these strains.
Likewise, the fact that candidalysin was secreted from R31A, R126A, R160A, R194A, and
R228A mutants (Table 1) indicates that candidalysin release from Ece1p is dependent
upon processing at Arg61 and Arg93 alone and is not inﬂuenced by mutations of Kex2p
recognition sites that do not directly border the toxin.
Mature candidalysin (terminating in K) is the predominant toxin secreted from WT
C. albicans. Given that the endoproteinase Kex2p cleaves protein substrates after
lysine-arginine (KR) motifs (8), it became apparent that a second cleavage event was
occurring that resulted in the removal of the C-terminal arginine residue from immature
candidalysin. The removal of C-terminal arginine residues from proteins and peptides
is the function of the carboxypeptidase Kex1p (23–25). To conﬁrm that removal of the
C-terminal arginine residue from immature candidalysin was due to the function of
Kex1p (3), we analyzed the hypha-secreted peptides of a kex1Δ/Δ null mutant com-
pared to its matched revertant strain. The dominant peptide secreted from the kex1Δ/Δ
null mutant was immature candidalysin (terminating in KR), whereas the kex1Δ/ΔKEX1
revertant showed WT-like secretion patterns (Table S2). This demonstrates that Kex1p
activity is an important requirement for candidalysin maturation. However, the biolog-
ical reason for removal of the C-terminal arginine residue by Kex1p is unclear, as both
immature (Ece1-III62–93KR) and mature (Ece1-III62–92K) candidalysin are able to damage
and activate epithelial cells, with Ece1-III62–93KR being even more cytolytic than mature
candidalysin at lower concentrations (3). We thus postulate that the removal of the
C-terminal arginine must confer an evolutionary advantage to C. albicans, either as a
commensal or as a pathogen. Furthermore, it is likely that Kex1p (like Kex2p) targets
multiple proteins and peptides in addition to immature candidalysin, which are also
required for fungal ﬁtness and virulence. These observations suggest that the immature
candidalysin secreted from C. albicans kex1Δ/Δ null mutant hyphae is not present in
sufﬁcient concentrations to cause damage to host epithelial cells if other fungal
attributes are dysfunctional. This could account for the attenuated damage potential of
the kex1Δ/Δ null mutant.
Exhausted culture medium from epithelial cells infected with WT C. albicans failed to
induce detectable damage on freshly cultured epithelial cells (not shown). The most
likely explanation for this observation is that the concentration of candidalysin secreted
into the extracellular environment is insufﬁcient to cause plasma membrane destabi-
lization. Indeed, we propose that in addition to correct processing of C. albicans Ece1p,
an epithelial invasion pocket produced by an invading hypha is also required in order
for secreted candidalysin to reach the concentrations necessary to cause epithelial
damage (3).
We also questioned whether extracellular aspartyl proteases, including Saps (17) and
Bar1p (21), could be involved in Ece1p processing and/or candidalysin maturation.
Culture of WT C. albicans under hypha-inducing conditions in the presence of the
aspartyl protease inhibitor pepstatin A followed by LC-MS/MS analysis of the hypha-
secreted peptides revealed that candidalysin secretion was unaffected (Table 1). Fur-
thermore, C. albicans mutant strains unable to express SAP2, SAP7, and SAP9/10 were
observed to cause epithelial damage and activation (3), suggesting that processing of
Ece1p and secretion of candidalysin were unaffected by these enzymes.
To determine whether defective Ece1p processing impacted C. albicans pathoge-
nicity in vivo, we utilized a murine model of OPC. Since mice are immunologically naive
to C. albicans, we ﬁrst investigated the ability of selected substitution mutants to induce
proinﬂammatory gene expression in the tongue tissue of immunocompetent mice.
Only those C. albicans mutants harboring substitutions at Arg61 and Arg93 (R61A,
R93A, R61A  R93A, and ALL KA), which ﬂank candidalysin, were severely diminished
in their ability to induce early-phase (24 h) gene expression, similar to the ece1Δ/Δ
Candidalysin Maturation from C. albicans Ece1p ®
January/February 2018 Volume 9 Issue 1 e02178-17 mbio.asm.org 11
 
m
bio.asm
.org
 o
n
 January 26, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
mutant (Fig. 3). This demonstrates that Ece1p processing at Arg61 and Arg93 and
subsequent candidalysin secretion are crucial for the induction of immune responses
against C. albicans in vivo. Given that C. albicans is not a natural colonizer of mice, we
next investigated the ability of the R61A  R93A and ALL KA substitution mutants to
colonize tongue tissue in an immunosuppressed OPC model. Both mutants showed a
reduced capacity to infect tongue tissue at 24 h, with signiﬁcant reductions in fungal
burdens observed with the ALL KA substitution mutant (Fig. 4A). Additional experi-
ments with the ALL KA substitution mutant indicated that fungal burdens remained
low after 48 h (Fig. 4B). We noted that while the R61A  R93A and ALL KA mutants
induced almost identical epithelial phenotypes in vitro (Fig. 1), they induced subtly
different phenotypes in the context of OPC in vivo after 24 h (Fig. 4A), with the ALL KA
mutant exhibiting a greater reduction in fungal burdens than the R61A R93A mutant.
This raises the possibility that candidalysin may have some residual activity when fused
to an adjacent peptide but not when contained within full-length Ece1p. Alternatively,
Ece1p processing at sites other than Arg61 and Arg93, and hence other Ece1p-derived
peptides, may have a role in fungal pathogenesis in vivo. Indeed, the role (if any) of the
other noncandidalysin peptides derived from Kex2p-Kex1p processing of Ece1p re-
mains to be determined. Investigations are under way to address this question.
In summary, this study demonstrates that the sequential two-step posttranslational
processing of C. albicans Ece1p by kexin-like proteinases is a critical event required for
candidalysin production, immune activation, and C. albicans pathogenicity. Site-speciﬁc
proteolytic degradation of Ece1p by the endoproteinase Kex2p releases immature
candidalysin, SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR (Ece1p6293), terminating with a
C-terminal arginine (Arg93). Following release from Ece1p, the immature toxin is further
processed by the carboxypeptidase Kex1p, which removes a C-terminal arginine to
yield mature candidalysin, SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK (Ece1p6292) (Fig. S1C).
The release of candidalysin from Ece1p can now be added to a growing list of protein
zymogens and peptide precursors that are targeted for proteolysis to produce smaller
biologically active molecules, including fungal killer toxins (23), hydrophobic plant
repellent peptides (26), mating pheromones (27), and mammalian prohormones (28).
Given the fundamental role of candidalysin in C. albicans virulence and the presence of
kexin-like proteinases in other human-pathogenic fungi, kexin-mediated processing
events and/or candidalysin itself may provide novel targets for the development of new
therapeutic drugs to treat fungal infections.
MATERIALS AND METHODS
Fungal strains. All fungal strains used in this study are presented in Table S3 in the supplemental
material (3, 16, 29, 30).
Oligonucleotides. Oligonucleotide primers were purchased from Integrated DNA Technologies
(Belgium). The sequence of primers used in this study is provided in Table S4.
Peptides. Peptides were purchased from Peptide Protein Research Ltd. (UK).
Antibodies. p-DUSP1/MKP1 (S359) and c-Fos rabbit monoclonal antibodies were purchased from
Cell Signaling Technologies (catalog numbers 2857 and 2250, respectively). Actin (clone C4) mouse
monoclonal antibody was purchased from Millipore (catalog number MAB1501). Peroxidase-conjugated
AfﬁniPure goat anti-mouse and anti-rabbit IgG secondary antibodies were purchased from Jackson
Immune Research (catalog numbers 115-035-062 and 111-035-003, respectively).
Mammalian cell culture. Experiments were performed using the TR146 human oral epithelial cell
line (31) (purchased from the European Collection of Authenticated Cell Cultures). Cells were cultured in
Dulbecco modiﬁed Eagle medium (DMEM)–F-12 nutrient mixture (1:1) plus L-glutamine (Life Technolo-
gies) supplemented with 15% (vol/vol) heat-inactivated fetal bovine serum (Life Technologies) and 1%
(vol/vol) penicillin-streptomycin (Sigma) at 37°C and 5% CO2.
Fungal cell culture. C. albicans strains were cultured in YPD medium (1% [wt/vol] yeast extract [Lab
M], 2% [wt/vol] peptone [Melford], 2% [wt/vol] dextrose [BDH]). Solid YPD medium was produced by
inclusion of 1.5% (wt/vol) agar (Melford). Transformed strains were cultured on synthetic deﬁned (SD)
medium (2% [wt/vol] dextrose [BDH], 0.67% [wt/vol] yeast nitrogen base without amino acids [Difco],
1.5% [wt/vol] agar [Melford]). Hyphal growth was induced by culturing fungal strains in RPMI 1640
medium (Life Technologies) for 3 h at 37°C and 5% CO2.
Infection of epithelial cells with C. albicans. Prior to infection, conﬂuent TR146 epithelial cells were
serum starved overnight, and all experiments were carried out in serum-free DMEM–F-12 medium. For
Western blotting, epithelial cells were infected with C. albicans strains at a multiplicity of infection (MOI)
of 10 for 2 h. For cytokine and damage assays, cells were infected at an MOI of 0.01 for 24 h. For c-Fos
Richardson et al. ®
January/February 2018 Volume 9 Issue 1 e02178-17 mbio.asm.org 12
 
m
bio.asm
.org
 o
n
 January 26, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
DNA binding assays, cells were infected at an MOI of 10 for 3 h. Following infection, cells were cultured
at 37°C and 5% CO2.
Construction of alanine substitution mutants in C. albicans Ece1p. The plasmid CIp10-ECE1 (3,
32), containing the ECE1 gene and its upstream and downstream intergenic regions, was used as a
parental template for site-directed mutagenesis. Site-directed mutagenesis was performed using the
QuikChange site-directed mutagenesis system (Agilent). Alanine substitutions in the ECE1 gene were
screened by restriction endonuclease digestion, and mutations were conﬁrmed by DNA sequencing.
Mutagenized constructs were linearized by digestion with StuI and concentrated by ethanol precipitation
prior to transformation.
Transformation of C. albicans. A uridine auxotrophic ece1 null mutant [ece1Δ/Δ (ura)] was
transformed with 15 g of linearized construct using a lithium acetate method modiﬁed from reference
33. Transformants were selected on SD agar medium and were restreaked onto fresh SD agar three times
to ensure stability, and genomic DNA was extracted using phenol-chloroform-isoamyl alcohol and glass
bead lysis. Successful integration of each construct into the C. albicans genome (at the RPS1 locus) was
conﬁrmed by PCR ampliﬁcation across the 5= and 3= integration sites.
Construction of KEX1 reintegrant. For complementation of the kex1Δ/Δ mutant (3), the KEX1 gene
plus upstream and downstream intergenic regions was ampliﬁed with primers KEX1-comp-F (including
a SalI restriction site) and KEX1-comp-R (including a ClaI restriction site) and cloned into SalI- and
ClaI-digested plasmid CIp10 (32), yielding CIp10-KEX1. After linearization with StuI, this plasmid was
transformed into a uridine auxotrophic kex1Δ/Δ strain, yielding the kex1Δ/ΔKEX1 complemented strain.
Preparation of protein extracts. Epithelial cells were lysed using a modiﬁed RIPA buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS)
containing protease (Sigma-Aldrich) and phosphatase (Perbio Science) inhibitors. Crude lysates were
cleared by centrifugation at 4°C, and protein concentration was estimated by bicinchoninic acid (BCA)
assay (Thermo Scientiﬁc) according to the manufacturer’s instructions.
SDS-PAGE and Western blotting. Proteins were resolved by electrophoresis on 12% SDS-PAGE gels
using a mini-Protean Tetra cell system (Bio-Rad). Electrophoresed proteins were transferred to a nitro-
cellulose membrane (Bio-Rad) using a mini-Transblot electrophoretic transfer cell (Bio-Rad). Membranes
were blocked in 1 Tris-buffered saline (TBS; Severn Biotech) containing 0.001% (vol/vol) Tween 20
(Acros Organics) and 5% (wt/vol) fat-free milk powder (Sainsbury’s). Primary antibodies diluted (1:1,000)
in TBS-Tween and 5% milk (c-Fos) or TBS-Tween and 5% bovine serum albumin (p-DUSP1/MKP1) were
added, and membranes were incubated overnight at 4°C with gentle shaking. Following incubation,
membranes were washed with 1 TBS containing 0.001% (vol/vol) Tween 20, diluted (1:10,000)
horseradish peroxidase (HRP)-conjugated secondary antibody was added, and membranes were incu-
bated for 1 h at room temperature. Membranes were washed as described above and exposed to
Immobilon Western chemiluminescent HRP substrate (Millipore) prior to visualization by exposure to ﬁlm
(GE Healthcare). Alpha-actin was used as a loading control.
Epithelial cell damage assay. Damage to epithelial monolayers was determined by quantiﬁcation
of lactate dehydrogenase activity using a CytoTox 96 nonradioactive cytotoxicity assay (Promega)
according to the manufacturer’s instructions. Porcine lactate dehydrogenase (Sigma) was used to create
the standard curve.
Quantiﬁcation of secreted cytokines. Exhausted cell culture medium was collected, and the
concentration of cytokines was determined using magnetic microparticles (R&D Systems) speciﬁc for
human IL-1, IL-1, IL-6, G-CSF, and GM-CSF (catalog numbers LUHM200, LUHM201, LUHM206,
LUHM214, and LUHM215, respectively) in conjunction with a magnetic Luminex performance assay
(Bio-Techne; catalog number LUHM000) and Bio-Plex 200 System (Bio-Rad) according to the manufac-
turer’s instructions.
Transcription factor (c-Fos) DNA binding assay. Epithelial cells were differentially lysed to recover
nuclear proteins using a nuclear protein extraction kit (Active Motif) according to the manufacturer’s
instructions, and 5 g of nuclear extract was quantiﬁed for c-Fos DNA binding activity using a TransAM
DNA binding assay (Active Motif) according to the manufacturer’s instructions.
Growth curve analysis. C. albicans mutant and control strains were cultured in YPD liquid medium
overnight at 30°C in a shaking incubator (180 rpm). Cultured cells were washed twice in sterile
phosphate-buffered saline (PBS), and absorbance (600 nm) was adjusted to 0.1 in YPD liquid medium,
using a Biochrom WPA CO8000 cell density meter. For each analysis, 200 l of adjusted culture was
added to three individual wells of a 96-well plate. The plate was sealed and maintained at 30°C, and the
absorbance (600 nm) was determined every 30 min using a Tecan Inﬁnite 200 Pro plate reader (Tecan
Instruments).
Hyphal length analysis. C. albicans mutant and control strains were cultured in YPD liquid medium
overnight at 30°C in a shaking incubator (180 rpm). Cultured cells were washed twice in sterile PBS and
adjusted to a concentration of 5  104 ml1 in RPMI 1640 medium. For each analysis, 1 ml of adjusted
culture was added to 2 individual wells of a 24-well plate, each containing a glass coverslip. The plate was
incubated at 37°C, 5% CO2, for 3 h, and after incubation, the wells were washed once with PBS and fungal
cells were ﬁxed in 4% paraformaldehyde, washed again, and stained with calcoﬂuor white. Coverslips
were mounted on microscopy slides, and images were taken of at least 50 fungal cells using ﬂuorescence
microscopy. Hyphal length was measured using the software ImageJ (34). Hypha branches were included
in the measurement, and nonﬁlamentous cells were assigned a hyphal length equal to 0.
Inhibition of secreted aspartic proteinase activity. C. albicans BWP17CIp30 was cultured under
hypha-inducing conditions in the presence of 50 M pepstatin A (Sigma) to inhibit the activity of Saps.
A control culture treated with an equivalent volume of ethanol (vehicle) was prepared in parallel.
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LC-MS/MS analysis of hypha-secreted Ece1p peptides. Analysis of hypha-secreted Ece1p peptides
was optimized for the detection of candidalysin and performed as previously described (3). The
methodology used is biased toward the detection of small peptides. Brieﬂy, Candida strains were
cultured for 18 h under strong hypha-inducing conditions {yeast nitrogen base [YNB] medium containing
2% sucrose, 75 mM MOPSO [3-(N-morpholino)-2-hydroxypropanesulfonic acid] buffer, pH 7.2, 5 mM
N-acetyl-D-glucosamine, 37°C}. Peptides secreted into the exhausted culture medium were enriched by
solid-phase extraction (SPE), passed through a 10-kDa-molecular-mass cutoff ﬁlter, and resolubilized in
0.2% formic acid in 71:27:2 (vol/vol/vol) acetonitrile (ACN)-H2O-dimethyl sulfoxide (DMSO). LC-MS/MS
analysis was performed using an Ultimate 3000 nano-LC coupled to a Q Exactive Plus mass spectrometer
(Thermo). Peptides were separated on an Accucore C4 column (15 cm by 75 m, 2.6 m) with a 60 min
LC gradient of (A) 0.2% HCOOH in 95:5 H2O-DMSO and (B) 0.2% HCOOH in 85:10:5 ACN-H2O-DMSO: 0 to
1.5 min at 60% B, 35 to 45 min at 96% B, and 45.1 to 60 min at 60% B. The top 10 precursor ions (full
scan at m/z 300 to 1,600, R  70k, full width at half maximum [FWHM]) per scan cycle underwent HCD
(high energy collisional dissociation) fragmentation (30 V). Resulting MS/MS spectra were monitored at
R  17.5k (FWHM). Proteome Discoverer 1.4 (Thermo) and the Sequest HT algorithm were used for
protein database searching against C. albicans SC5314 (Candida Genome Database [http://www
.candidagenome.org]). Mass spectra were searched for both unspeciﬁc cleavages (no enzyme) and tryptic
peptides up to 4 missed cleavages. The precursor mass tolerance was 10 ppm, and the fragment mass
tolerance was 0.02 Da. At least two unique peptides per protein, a false discovery rate of 1%, and
cross-correlation (Xcorr) validation (from 2.0 at z 2 up to 3.0 at z 6) were required for positive protein
hits.
RNA extraction from fungi. C. albicans mutant and control strains were cultured in YPD liquid
medium overnight at 30°C in a shaking incubator (180 rpm). Cells were washed twice in PBS, and the
concentration was adjusted to 1  107 cells ml1 in 25 ml RPMI 1640 (hypha inducing) or 5 ml YPD
(yeast). For hyphal samples, fungal suspensions were distributed in 150-cm2 petri dishes and incubated
at 37°C and 5% CO2 for 3 h. After incubation, medium and nonadherent Candida cells were discarded.
Adherent Candida cells were rinsed once with ice-cold PBS, loosened with a cell scraper, and collected.
For yeast samples, fungal suspensions were cultured at 30°C for 3 h in a shaking incubator (180 rpm).
After incubation, cells were collected by centrifugation (3,000  g for 2 min at 4°C) and resuspended in
10 ml ice-cold PBS. Hyphae and yeast samples were washed again with 1 ml ice-cold PBS and centrifuged
(3,000  g, 2 min, 4°C), the supernatant was removed, and cell pellets were snap-frozen in liquid
nitrogen. Frozen Candida pellets were thawed in 600 l RLT buffer (Qiagen) containing 1%
-mercaptoethanol, mixed with 300 l acid-washed glass beads (diameter, 0.5 mm), and bead beaten
twice at 5,500 rpm for 15 s. Lysates were centrifuged for 2 min at 20,000  g, 4°C, the supernatant was
mixed with an equal volume of 70% ethanol (prepared in diethyl pyrocarbonate [DEPC]-water), and total
RNA was isolated using the RNeasy minikit (Qiagen) according to the manufacturer’s instructions. RNA
integrity and concentration were conﬁrmed using a Bioanalyzer (Agilent).
Quantiﬁcation of C. albicans ECE1 gene expression. RNA (500 ng) was treated with DNase
(Epicentre), and cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen). cDNA
samples were used for qPCR with EvaGreen mix (Bio&Sell). Primers (ACT1-F and ACT1-R for ACT1 and
ECE1-F2 and ECE1-R for ECE1 [Table S4]) were used at a ﬁnal concentration of 500 nM. qPCR ampliﬁca-
tions were performed using a CFX96 thermocycler (Bio-Rad). ECE1 expression was calculated using the
threshold cycle (ΔΔCT) method, with ACT1 as the reference gene and C. albicans reference strain SC5314
(yeast morphology) as the control sample.
Nonimmunosuppressed model of OPC infection. BALB/c mice were purchased from Harlan and
housed at King’s College London. A murine model of oropharyngeal candidiasis (OPC) (35) was modiﬁed
to investigate early-phase gene expression responses to selected C. albicans alanine substitution mutants
and controls. Brieﬂy, nonimmunosuppressed female BALB/c mice (6 to 8 weeks old, 22 to 25 g) were
sedated for 75 min with an intraperitoneal injection of 110 mg/kg of body weight ketamine and 8 mg/kg
xylazine, and a swab soaked in sterile saline (vehicle) or 1 107 CFU ml1 of C. albicans yeast culture (WT,
ece1Δ/Δ, ece1Δ/ΔECE1, ece1Δ/ΔECE1Δ184–279, R31A, R61A, R93A, R61  R93A, and ALL KA) in sterile
saline was placed sublingually for 75 min. After 24 h, mice were sacriﬁced, the tongue was excised, and
RNA was extracted as described below.
RNA extraction from murine tissue. Murine tongue tissue was homogenized in RLT lysis buffer
(Qiagen) containing 1% -mercaptoethanol using a gentleMACs dissociator (Miltenyi Biotec), and RNA
was extracted using an RNeasy Plus minikit (Qiagen) according to the manufacturer’s instructions.
Quantiﬁcation of gene expression from murine tissue. RNA (600 ng) was treated with Turbo
DNase (Invitrogen), and cDNA was synthesized using Superscript IV reverse transcriptase (Invitrogen).
cDNA samples were used for qPCR with FIREpol EvaGreen qPCR Mix Plus (ROX) (Solis BioDyne). Primers
(complementary to murine beta-actin, Ccl20, Il1b, Il6, and Csf3 [Table S4]) were used at a ﬁnal concen-
tration of 400 nM. qPCR ampliﬁcations were performed using a RotorGene qPCR system (Corbett). Gene
expression was calculated using the two-standard-curve method with murine beta-actin as the reference
gene.
Murine model of oropharyngeal candidiasis. BALB/c mice were purchased from The Jackson
Laboratory and housed at the University of Pittsburgh. Mice were injected subcutaneously with
225 mg/kg cortisone acetate (prepared in 0.05% Tween 20-PBS solution) 1 day before infection. The OPC
experiment was performed the following day. Mice were sedated with an intraperitoneal injection of
ketamine-xylazine solution (15 mg ml1 ketamine, 1.5 mg ml1 xylazine prepared in sterile saline). A 2.5
mg cotton ball was soaked in C. albicans solution (1  107 CFU ml1 in sterile PBS) and placed
sublingually for 75 min as described in reference 36. Oral swabs were obtained before every experiment
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to verify the absence of commensal fungi. Mice were sacriﬁced, the tongue was excised, tissue
homogenates were prepared on a gentleMACS dissociator (Miltenyi Biotec), and CFU were determined
by plating serial dilutions on YPD agar supplemented with 50 g ml1 ampicillin.
Statistical analysis. All data were analyzed by one-way analysis of variance (ANOVA) with a post hoc
Dunnett comparison test. In all cases, P  0.05 was taken to be signiﬁcant. Where data are expressed as
“fold change versus vehicle control,” a log transformation was performed prior to performing statistical
analysis, to ensure a normal distribution of data.
Ethics statement. Murine infections were performed under UK Home Ofﬁce project license PPL
70/7598 in dedicated animal facilities at King’s College London and under U.S. license 14125154
(with modiﬁcation number IM-14125154-21). All protocols were approved by the King’s College
London ethical review board and the University of Pittsburgh IACUC. Power analysis was used to
predetermine sample size. No method of randomization was used to allocate animals to experi-
mental groups. Mice in the same cage were part of the same treatment. The investigators were not
blind during outcome assessment.
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